113 related articles for article (PubMed ID: 9342753)
1. Tenascin expression in elastotic cuffs of invasive ductal carcinoma of the breast.
Melis M; Baiocchini A; Soda G; Bosco D
Pathol Res Pract; 1997; 193(7):479-84. PubMed ID: 9342753
[TBL] [Abstract][Full Text] [Related]
2. Elastosis in breast carcinoma: I. Immunohistochemical characterization of elastic fibres.
Mera SL; Davies JD
J Pathol; 1987 Feb; 151(2):103-10. PubMed ID: 3033189
[TBL] [Abstract][Full Text] [Related]
3. Tenascin-A marker for the malignant potential of preinvasive breast cancers.
Goepel C; Buchmann J; Schultka R; Koelbl H
Gynecol Oncol; 2000 Dec; 79(3):372-8. PubMed ID: 11104607
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
[TBL] [Abstract][Full Text] [Related]
5. Elastosis in breast--correlation with epithelial proliferation in benign disease and carcinomatous growth.
Khatun N; Arihiro K; Inai K
Hiroshima J Med Sci; 1992 Dec; 41(4):87-100. PubMed ID: 1293074
[TBL] [Abstract][Full Text] [Related]
6. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
Ishihara A; Yoshida T; Tamaki H; Sakakura T
Clin Cancer Res; 1995 Sep; 1(9):1035-41. PubMed ID: 9816077
[TBL] [Abstract][Full Text] [Related]
7. Elastin gene expression in elastotic human breast cancers and epithelial cell lines.
Krishnan R; Cleary EG
Cancer Res; 1990 Apr; 50(7):2164-71. PubMed ID: 2156612
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
9. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
Dandachi N; Hauser-Kronberger C; Moré E; Wiesener B; Hacker GW; Dietze O; Wirl G
J Pathol; 2001 Feb; 193(2):181-9. PubMed ID: 11180164
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Tökés AM; Hortoványi E; Csordás G; Kulka J; Mózes G; Hatalyák A; Kádár A
Anticancer Res; 1999; 19(1A):175-9. PubMed ID: 10226540
[TBL] [Abstract][Full Text] [Related]
14. [Tenascin-C expression in human breast tumors].
Tökés AM; Kulka J
Orv Hetil; 2003 Sep; 144(39):1901-7. PubMed ID: 14598568
[TBL] [Abstract][Full Text] [Related]
15. Elastosis in breast carcinoma.
Gădăleanu V; Galatâr N; Nestor D
Morphol Embryol (Bucur); 1981; 27(4):347-51. PubMed ID: 6276735
[TBL] [Abstract][Full Text] [Related]
16. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
17. Elastosis in relation to prognosis in primary breast carcinoma.
Rasmussen BB; Pedersen BV; Thorpe SM; Rose C
Cancer Res; 1985 Mar; 45(3):1428-30. PubMed ID: 3971386
[TBL] [Abstract][Full Text] [Related]
18. Stromal elastosis in papillary thyroid carcinomas.
Kondo T; Nakazawa T; Murata S; Katoh R
Hum Pathol; 2005 May; 36(5):474-9. PubMed ID: 15948113
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of intratumoural variations in elastosis grades and the oestrogen receptor status of human breast carcinomas.
Giri DD; Lonsdale RN; Dangerfield VJ; Harris SC; Parsons MA; Underwood JC
J Pathol; 1987 Apr; 151(4):297-303. PubMed ID: 3585588
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C
Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]